Danaher EPS - Earnings per Share 2010-2024 | DHR

Danaher annual and quarterly earnings per share history from 2010 to 2024. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
  • Danaher EPS for the quarter ending December 31, 2024 was $1.49, a 3.47% increase year-over-year.
  • Danaher EPS for the twelve months ending December 31, 2024 was $5.28, a 17.24% decline year-over-year.
  • Danaher 2024 annual EPS was $5.29, a 17.08% decline from 2023.
  • Danaher 2023 annual EPS was $6.38, a 33.95% decline from 2022.
  • Danaher 2022 annual EPS was $9.66, a 12.2% increase from 2021.
Danaher Annual EPS
2024 $5.29
2023 $6.38
2022 $9.66
2021 $8.61
2020 $4.89
2019 $4.05
2018 $3.74
2017 $3.53
2016 $3.65
2015 $4.74
2014 $3.63
2013 $3.80
2012 $3.36
2011 $3.11
2010 $2.64
2009 $1.73
Danaher Quarterly EPS
2024-12-31 $1.49
2024-09-30 $1.12
2024-06-30 $1.22
2024-03-31 $1.45
2023-12-31 $1.44
2023-09-30 $1.51
2023-06-30 $1.49
2023-03-31 $1.94
2022-12-31 $3.00
2022-09-30 $2.10
2022-06-30 $2.25
2022-03-31 $2.31
2021-12-31 $2.38
2021-09-30 $1.54
2021-06-30 $2.40
2021-03-31 $2.29
2020-12-31 $1.68
2020-09-30 $1.16
2020-06-30 $1.24
2020-03-31 $0.81
2019-12-31 $1.73
2019-09-30 $0.89
2019-06-30 $0.97
2019-03-31 $0.46
2018-12-31 $1.06
2018-09-30 $0.93
2018-06-30 $0.95
2018-03-31 $0.80
2017-12-31 $1.21
2017-09-30 $0.81
2017-06-30 $0.79
2017-03-31 $0.72
2016-12-31 $1.06
2016-09-30 $0.56
2016-06-30 $0.94
2016-03-31 $1.09
2015-12-31 $0.97
2015-09-30 $2.01
2015-06-30 $0.97
2015-03-31 $0.79
2014-12-31 $0.92
2014-09-30 $0.95
2014-06-30 $0.95
2014-03-31 $0.81
2013-12-31 $1.11
2013-09-30 $0.84
2013-06-30 $0.87
2013-03-31 $0.98
2012-12-31 $0.89
2012-09-30 $0.77
2012-06-30 $0.84
2012-03-31 $0.86
2011-12-31 $0.80
2011-09-30 $0.74
2011-06-30 $0.94
2011-03-31 $0.63
2010-12-31 $0.69
2010-09-30 $0.95
2010-06-30 $0.55
2010-03-31 $0.45
2009-12-31 $0.40
2009-09-30 $0.53
2009-06-30 $0.44
2009-03-31 $0.36
Sector Industry Market Cap Revenue
Medical Medical Services $151.685B $23.875B
Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products. The company's segmental details are provided below: Life Sciences segment offers a broad range of research tools used to analyze a range of critical areas including genes, proteins, metabolites and cells to understand the causes of diseases, identify new therapies, and test new drugs and vaccines. Range of industries served includes biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial. Diagnostics segment offers analytical instruments, reagents, consumables, software and services that are deployed in reference laboratories, hospitals, physicians' offices and other critical care settings. It helps to diagnose diseases and take suitable treatment decisions. Environmental & Applied Solutions segment offers products and services that help keep food and water supplies safe globally.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $90.559B 11.84
Cencora (COR) United States $47.572B 17.32
Natera (NTRA) United States $23.122B 0.00
DiDi Global (DIDIY) China $22.844B 0.00
ICON (ICLR) Ireland $16.164B 14.40
Avantor (AVTR) United States $14.769B 22.14
Revvity (RVTY) United States $14.502B 24.32
BioMerieux (BMXMF) France $14.256B 0.00
Viatris (VTRS) United States $13.010B 4.01
Solventum (SOLV) United States $12.919B 0.00
CochLear (CHEOY) Australia $12.848B 0.00
Medpace Holdings (MEDP) United States $11.220B 31.61
Doximity (DOCS) United States $10.877B 56.56
EUROFINS SCIENT (ERFSF) Luxembourg $10.037B 0.00
HealthEquity (HQY) United States $9.712B 48.73
Sonic Healthcare (SKHHY) Australia $8.513B 0.00
Charles River Laboratories (CRL) United States $8.502B 16.43
Amplifon S.p.A (AMFPF) Italy $6.136B 31.28
Bausch + Lomb (BLCO) Canada $5.661B 26.33
BrightSpring Health Services (BTSG) United States $3.913B 83.22
Sotera Health (SHC) United States $3.909B 20.91
Organon (OGN) United States $3.835B 3.87
Surgery Partners (SGRY) United States $3.260B 37.17
Concentras Parent (CON) United States $2.958B 0.00
Alignment Healthcare (ALHC) United States $2.885B 0.00
PACS (PACS) United States $2.161B 0.00
Ardent Health Partners (ARDT) United States $2.121B 0.00
Teladoc Health (TDOC) United States $2.061B 0.00
Progyny (PGNY) United States $1.859B 37.64
GoodRx Holdings (GDRX) United States $1.837B 48.20
Premier (PINC) United States $1.821B 11.08
GeneDx Holdings (WGS) United States $1.708B 0.00
Ryman Healthcare (RYHTY) New Zealand $1.409B 0.00
Agilon Health (AGL) United States $1.351B 0.00
CareDx (CDNA) United States $1.217B 0.00
Pediatrix Medical (MD) United States $1.177B 11.51
Embecta (EMBC) United States $1.031B 7.06
AMN Healthcare Services Inc (AMN) United States $0.993B 6.72
Establishment Labs Holdings (ESTA) $0.848B 0.00
Auna S.A (AUNA) Luxembourg $0.602B 0.00
SBC Medicals (SBC) United States $0.533B 0.00
DocGo (DCGO) United States $0.501B 18.89
Sonida Senior Living (SNDA) United States $0.464B 0.00
InnovAge Holding (INNV) United States $0.435B 0.00
Enhabit (EHAB) United States $0.414B 35.83
QDM (QDMI) Hong Kong, SAR China $0.382B 10.00
MultiPlan (MPLN) United States $0.352B 0.00
Nutex Health (NUTX) United States $0.323B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.317B 0.00
LifeMD (LFMD) United States $0.270B 0.00
Beauty Health (SKIN) United States $0.201B 0.00
Performant Healthcare (PHLT) United States $0.185B 0.00
Sera Prognostics (SERA) United States $0.159B 0.00
Biodesix (BDSX) United States $0.151B 0.00
So-Young (SY) China $0.104B 17.63
Ascend Wellness Holdings (AAWH) United States $0.086B 0.00
IceCure Medical (ICCM) Israel $0.072B 0.00
Oncology Institute (TOI) United States $0.067B 0.00
ModivCare (MODV) United States $0.062B 3.35
NeueHealth (NEUE) United States $0.061B 1.61
Singular Genomics Systems (OMIC) United States $0.050B 0.00
OncoCyte (OCX) United States $0.035B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.031B 0.00
Co-Diagnostics (CODX) United States $0.022B 0.00
Pheton Holdings (PTHL) China $0.019B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.009B 0.00
KindlyMD (KDLY) United States $0.007B 0.00
BioNexus Gene Lab (BGLC) $0.007B 0.00
XWELL (XWEL) United States $0.006B 0.00
Aclarion (ACON) United States $0.003B 0.00
ISpecimen (ISPC) United States $0.002B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00